NCT03194828

Real-time Glaucoma Medication Adherence

Leveraging Real-Time Medication Use Monitoring to Improve Adherence in Adults With Glaucoma

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 5 (actual)
• Sponsor: University of Tennessee · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study will evaluate the effectiveness of real-time data collected on patients taking topical medication to treat glaucoma. Patients will be randomized to two groups, the first of which will only use the study device to take their medication, while the second will use the study device and receive on-demand reminder messages, when necessary.

Detailed description

Adherence to topical medications to treat glaucoma remains sub optimal; however, our understanding of this behavior remains limited due to biased measures of medication use. The Kali Drop device is a potential improvement in our ability to capture medication use in patients using dropper bottles by precisely capturing the amount dispensed in real-time. Moreover, such technology creates data that can be leveraged into driving behavior change using connected mobile technology in order to improve adherence and, ultimately, health outcomes. While evidence suggests that reminders may improve adherence to glaucoma medications, the power of doing so using real-time data has yet to be explored. This study will compare simple monitoring of patients to those who are being monitored and who receive reminder messages when the system determines one is necessary due to a missed dose.

Conditions

• Glaucoma

Interventions

Type	Name	Description
BEHAVIORAL	Medication reminder	Using the real-time data capture of the electronic device, an automated voice call or text message will be sent to active arm participants only when a missed dose is determined
BEHAVIORAL	Medication monitoring only	Patients will use an electronic medication monitoring device to record their actual medication use

Timeline

• Start date: 2017-05-08
• Primary completion: 2018-07-15
• Completion: 2018-07-15
• First posted: 2017-06-21
• Last updated: 2018-11-07

Locations

8 sites across 1 country: United States